Home/Filings/4/0001140361-14-010646
4//SEC Filing

Regado Biosciences Inc 4

Accession 0001140361-14-010646

CIK 0001311596operating

Filed

Mar 2, 7:00 PM ET

Accepted

Mar 3, 6:22 PM ET

Size

19.9 KB

Accession

0001140361-14-010646

Insider Transaction Report

Form 4
Period: 2014-02-20
Transactions
  • Exercise of In-Money

    Common Stock, par value $0.001 per share

    2014-02-20$4.51/sh+5,447$24,5661,122,301 total(indirect: See Footnote)
  • Exercise of In-Money

    Common Stock, par value $0.001 per share

    2014-02-20$0.17/sh+4,491$7631,130,133 total(indirect: See Footnote)
  • Exercise of In-Money

    Stock Option (right to buy)

    2014-02-2010 total(indirect: See Footnote)
    Exercise: $4.51Exp: 2020-04-30Common Stock (3,341 underlying)
  • Exercise of In-Money

    Stock Option (right to buy)

    2014-02-2010 total(indirect: See Footnote)
    Exercise: $3.34Exp: 2015-12-20Common Stock (2,095 underlying)
  • Exercise of In-Money

    Common Stock, par value $0.001 per share

    2014-02-20$3.34/sh+2,095$6,9971,116,854 total(indirect: See Footnote)
  • Exercise of In-Money

    Common Stock, par value $0.001 per share

    2014-02-20$4.51/sh+3,341$15,0681,125,642 total(indirect: See Footnote)
  • Exercise of In-Money

    Stock Option (right to buy)

    2014-02-2010 total(indirect: See Footnote)
    Exercise: $4.51Exp: 2020-04-30Common Stock (5,447 underlying)
  • Exercise of In-Money

    Warrant (right to buy)

    2014-02-2010 total(indirect: See Footnote)
    Exercise: $0.17Exp: 2014-02-20Common Stock (4,491 underlying)
Footnotes (5)
  • [F1]The Reporting Person holds the reportable securities as nominee for Aurora Ventures IV, LLC ("Aurora IV"). The Reporting Person is the manager of A.V. Management IV, L.L.C., the managing member of Aurora IV, and may be deemed to share voting and investment power. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F2]The Reporting Person holds the reportable securities as nominee for Aurora Ventures V, LP ("Aurora V"). The Reporting Person is the Manager of A.V. Management V, L.L.C., the managing member of Aurora V, and may be deemed to share voting and investment power. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report is not an admission that he is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
  • [F3]This option was fully vested and exercisable as of December 20, 2006.
  • [F4]This option was fully vested and exercisable as of December 31, 2010.
  • [F5]This warrant was exercisable as of November 20, 2004.

Documents

1 file

Issuer

Regado Biosciences Inc

CIK 0001311596

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001311596

Filing Metadata

Form type
4
Filed
Mar 2, 7:00 PM ET
Accepted
Mar 3, 6:22 PM ET
Size
19.9 KB